CAM
JAZZ icon

Capstone Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Capstone Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,309
Closed -$563K – 1606
2016
Q1 		$563K Buy
4,309
+900
+26% +$112K 0.02% 851
2015
Q4 		$479K Buy
3,409
+970
+40% +$134K 0.01% 949
2015
Q3 		$324K Buy
2,439
+490
+25% +$84.4K 0.01% 1180
2015
Q2 		$343K Buy
1,949
+31
+2% +$5.57K 0.01% 1222
2015
Q1 		$331K Buy
1,918
+41
+2% +$7.04K 0.01% 1336
2014
Q4 		$307K Sell
1,877
-22
-1% -$3.65K 0.01% 1360
2014
Q3 		$305K Hold
1,899
– – 0.01% 1338
2014
Q2 		$279K Sell
1,899
-352
-16% -$48.8K 0.01% 1426
2014
Q1 		$312K Sell
2,251
-380
-14% -$57.2K 0.01% 1391
2013
Q4 		$333K Sell
2,631
-3,051
-54% -$316K 0.01% 1444
2013
Q3 		$523K Buy
5,682
+1,630
+40% +$131K 0.01% 1253
2013
Q2 		$278K Buy
+4,052
New +$248K 0.01% 1619

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capstone Asset Management's JAZZ Position: Q2 2016 in Review

Capstone Asset Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2016, closing a stake of 4,309 shares — an estimated $563K sold.

Capstone Asset Management first reported a position in JAZZ in Q2 2013 and held it in 12 quarters. The position peaked at $563K in Q1 2016. 366 funds tracked by Wall St. Rank hold JAZZ as of Q2 2016.

  • Capstone Asset Management reported no remaining Jazz Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Capstone Asset Management sold 4,309 Jazz Pharmaceuticals shares in Q2 2016, an estimated $563K.
  • Capstone Asset Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 12 quarters.
  • Capstone Asset Management's Jazz Pharmaceuticals position peaked at $563K in Q1 2016.
  • 366 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2016.

Based on Capstone Asset Management's 13F filing for Q2 2016, filed 13 Jul 2016.